Simon Read, Ph.D.
Independent DirectoratDianthus Therapeutics, Inc. /DE/· In the 2025 proxy
Simon Read, Ph.D. sits on 1 public board.
Experience
- Dianthus Therapeutics, Inc. /DE/Public company · 1 yr
- Independent Director2025 – Present · 1 yrStock in role +259%
- Triana BiomedicinesPublic company · 2 yr
- Director2022 – 2024 · 2 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?